Xtant Medical Holdings (XTNT) EBIT Growth (3y) (2013 - 2025)
Xtant Medical Holdings (XTNT) EBIT Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 13.06% |
| 10 | Xtant Medical Holdings | 46.30 Mn | 28.69 Mn | 17.75 Mn | 130.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 130.82% |
| Sep 30, 2025 | 49.44% |
| Jun 30, 2025 | 77.12% |
| Mar 31, 2025 | 37.16% |
| Dec 31, 2024 | 0.51% |
| Sep 30, 2024 | -37.75% |
| Jun 30, 2024 | -81.71% |
| Mar 31, 2024 | -785.36% |
| Dec 31, 2023 | -161.38% |
| Sep 30, 2023 | -86.18% |
| Jun 30, 2023 | -53.18% |
| Mar 31, 2023 | -4.96% |
| Dec 31, 2022 | -75.67% |
| Sep 30, 2022 | -39.16% |
| Jun 30, 2022 | -32.17% |
| Mar 31, 2022 | -39.95% |
| Dec 31, 2021 | 67.31% |
| Sep 30, 2021 | -0.23% |
| Jun 30, 2021 | 39.89% |
| Mar 31, 2021 | 85.55% |